CLINICAL-FEATURES AND OUTCOME OF 80 PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
GABRIELLI, A [1 ]
CORVETTA, A [1 ]
MONTRONI, M [1 ]
RICCIATTI, AM [1 ]
NITTI, C [1 ]
DANIELI, MG [1 ]
DANIELI, G [1 ]
机构
[1] UNIV ANCONA,IST CLIN MED,I-60100 ANCONA,ITALY
来源
JOURNAL OF IMMUNOLOGICAL RESEARCH | 1991年 / 3卷 / 04期
关键词
MORBIDITY; MORTALITY; SYSTEMIC LUPUS ERYTHEMATOSUS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The spectrum of organ involvement and outcome of 80 patients with Systemic Lupus Erythematosus (SLE) have been assessed in a retrospective study. Joint manifestations and constitutional symptoms were the most common features. Nephritis was present in 16 patients at disease onset and developed in further 21 during the course of their disease. Patients with late-onset SLE (after age 50; 33.3%) had a lower incidence of renal disease similar to that found in patients younger than 20 years (26.3%). The mean interval from onset of first symptoms to diagnosis was shorter in patients evaluated from 1984 to 1989: 7.2 months versus 24.9 months of the patients first seen in the previous six years. Eight deaths occurred (10%) and lupus-related organ or system involvement (mainly CNS and active nephritis) were the most frequent primary causes of death. Two of the patients who died of cerebrovascular disease had high anticardiolipin antibodies and in a third the level was borderline. This finding implies that antiphospholipid immunity may be an important contributing cause of death and underscores the urgency of an appropriate treatment of this abnormality.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 50 条
  • [41] CLINICAL AND LABORATORY FEATURES OF 30 PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND SILICONE BREAST IMPLANTS
    BASBUG, E
    SCHWARTZ, E
    WALLACE, DJ
    NESSIM, S
    KLINENBERG, JR
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 670 - 670
  • [42] CLINICAL SUBSET OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    REYES, PA
    LAVALLE, C
    ARTHRITIS AND RHEUMATISM, 1980, 23 (09): : 1064 - 1065
  • [43] CLINICAL SPECTRUM OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    PEREZ, AG
    REVISTA CLINICA ESPANOLA, 1987, 181 (06): : 293 - 295
  • [44] CLINICAL ASPECTS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    FRIES, JF
    MEDICAL CLINICS OF NORTH AMERICA, 1977, 61 (02) : 229 - 240
  • [45] SYSTEMIC LUPUS-ERYTHEMATOSUS CLINICAL ISSUES
    STEVENS, MB
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (2-3): : 251 - 270
  • [46] PREGNANCY AND ITS OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    HUONG, DLT
    WECHSLER, B
    PIETTE, JC
    BLETRY, O
    GODEAU, P
    QUARTERLY JOURNAL OF MEDICINE, 1994, 87 (12): : 721 - 729
  • [47] SEROLOGICAL FEATURES OF THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    KABURAKI, J
    KUWANA, M
    YAMAMOTO, M
    KAWAI, S
    IKADA, Y
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 103 - 103
  • [48] PREGNANCY OUTCOME IN WOMEN WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    GIMOVSKY, ML
    MONTORO, M
    PAUL, RH
    OBSTETRICS AND GYNECOLOGY, 1984, 63 (05): : 686 - 692
  • [49] OUTCOME OF RENAL LESIONS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    NIAUDET, P
    BERTEROTTIERE, D
    LACOSTE, M
    BEZIAU, A
    HABIB, R
    ANNALES DE PEDIATRIE, 1991, 38 (06): : 427 - 433
  • [50] B-CELL HYPERACTIVITY AND ITS RELATION TO DISTINCT CLINICAL-FEATURES AND THE DEGREE OF DISEASE-ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SAKANE, T
    SUZUKI, N
    TAKADA, S
    UEDA, Y
    MURAKAWA, Y
    TSUCHIDA, T
    YAMAUCHI, Y
    KISHIMOTO, T
    ARTHRITIS AND RHEUMATISM, 1988, 31 (01): : 80 - 87